亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

萊佛士制藥技術有限公司  

醫藥中間體和原料藥;有機催化劑;提供國際水準的綠色工藝開發、定制合成與生產等方面的服務

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:莫先生
  • 電話:0752-5538396
  • QQ:2634038916
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 221615-72-1
221615-72-1
單價 面議對比
詢價 暫無
發貨 廣東惠州市付款后3天內
品牌 RAFFLES
規格 1-10g;100g;500g;1kg;10kg
純度 ≥98%
貨期 1-2 周
過期 長期有效
更新 2016-08-15 10:07
 
詳細信息
 
中文名稱: 1-(6-甲基-3-吡啶)-2-[4-(甲巰基)苯基]-乙酮
中文同義詞: 1-(6-甲基-3-吡啶)-2-[4-(甲巰基)苯基]-乙酮;依托考昔中間體1-(6-甲基-3-吡啶)-2-[4-(甲巰基)苯基]-乙酮;1-(6-甲基-3-吡啶)-2-[4-(甲巰基)苯基]-乙酮(依托考昔中間體);1-(6-甲基吡啶-3-基)-2-[4-(甲硫基)苯基]乙酮
英文名稱: 1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone
英文同義詞: 1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone;1-(6-Methyl-3-pyridinyl)-2-[4-(Methylthio)phenyl]-ethanone
CAS號: 221615-72-1
分子式: C15H15NOS
分子量: 257.3507
EINECS號: -0
相關類別: inter;吡啶;酮;醫藥中間體
Mol文件: 221615-72-1.mol
1-(6-甲基-3-吡啶)-2-[4-(甲巰基)苯基]-乙酮
©2025 萊佛士制藥技術有限公司 版權所有   技術支持:化工網   訪問量:2764  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |